Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  206.40
-3.71 (-1.77%)
AAPL  264.94
+0.36 (0.14%)
AMD  198.21
-1.94 (-0.97%)
BAC  52.84
-0.23 (-0.42%)
GOOG  316.58
+1.68 (0.53%)
META  650.14
-5.52 (-0.84%)
MSFT  388.07
-9.16 (-2.31%)
NVDA  192.69
+2.87 (1.51%)
ORCL  141.98
-6.10 (-4.12%)
TSLA  403.30
-8.52 (-2.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.